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Abstract
Cirrhotic patients (23 with alcoholic cirrhosis, 5 with posthepatitic
cirrhosis and 2 with cryptogenic cirrhosis) with ascites and portal
hypertension were studied and divided into two groups corresponding
to high or low risk to develop spontaneous bacterial peritonitis (SBP)
related to the concentration of total protein in the ascitic fluid (A-TP):
group I (high risk): A-TP≤1.5 g/dl and group II (low risk): A-TP>1.5
g/dl. Fibronectin (FN), C3 and C4 concentrations were measured by
radial immunodiffusion while total protein was measured by the biuret
method. The mean values (group I vs group II) of C3 (12.59 ± 4.72 vs
24.53 ± 15.58 mg/dl), C4 (4.26 ± 3.87 vs 7.26 ± 4.14 mg/dl) and FN
(50.47 ± 12.49 vs 75.89 ± 24.70 mg/dl) in the ascitic fluid were
significantly lower (P<0.05) in the group considered to be at high risk
for SBP. No significant difference was observed in the plasma/ascites
fibronectin ratio (3.91 ± 1.21 vs 3.80 ± 1.26) or gradient (131.46 ±
64.01 vs 196.96 ± 57.38) between groups. Fibronectin in ascites was
significantly correlated to C3 (r = 0.76), C4 (r = 0.58), total protein (r
= 0.73) and plasma FN (r = 0.58) (P<0.05). The data suggest that the
FN concentration in ascites is related to the opsonic capacity of this
fluid, and that its concentration in the ascitic fluid may be a biochemi-
cal risk factor indicator for the development of spontaneous bacterial
peritonitis.
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Introduction
Many studies have shown that cirrhotic
patients present a deficiency in the opsonic
activity of the ascitic fluid (1-3), which is
related to low levels of total protein, C3, and
C4 (2-4), thus predisposing the patient to-
wards spontaneous bacterial peritonitis
(SBP). While fibronectin (FN) is a glycopro-
tein involved in the mechanism of non-spe-
cific opsonization of a number of endoge-
nous substances and bacteria (5,6), its diag-
nostic significance as well as its physio-
pathological role in the ascitic fluid are not
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yet completely understood (7,8).
The ascitic fluid of cirrhotic patients dis-
plays lower fibronectin concentration when
compared with that of noncirrhotic patients
(7,9), which may be related to the higher
infection risk of these patients (7,10). How-
ever, few studies have measured the concen-
tration of this glycoprotein in the ascitic
fluid of cirrhotic patients who developed
SBP and the results have been inconsistent
(4,7,10), as was also the case for studies
determining the correlation between FN and
biochemical risk factors for SBP, in particu-
lar total protein (8,11).
Therefore, we determined the fibronec-
tin concentration in the ascitic fluid and
plasma of cirrhotic patients without a previ-
ous history of SBP and correlated it with
biochemical parameters considered to be risk
factors for development of SBP, in particu-
lar total protein and the C3 and C4 fractions
of the complement.
Patients and Methods
Thirty patients, 25 males and 5 females
(mean age, 51.2 years), presenting liver cir-
rhosis (23 with alcoholic cirrhosis, 5 with
posthepatitic cirrhosis and 2 with cryptoge-
nic etiology) and ascites detected by physi-
cal examination were studied. Cirrhosis was
diagnosed by hepatic biopsy and clinical and
biochemical criteria (12), as well as by imag-
ing and endoscopy.
None of the patients had been submitted
to paracentesis, had a history of SBP, pre-
sented clinical or bacteriological evidence
of systemic infection, or had received antibi-
otic therapy for thirty days prior to entering
the study. Only those patients whose ascitic
fluid presented cellularity levels lower than
250 polymorphonuclear neutrophils/mm3
with negative culture and neoplastic cell as-
say and a plasma-ascites albumin gradient
greater than 1.1 g/dl were included in the
study.
The patients were divided into two groups
according to the total protein concentration
in the ascitic fluid (A-TP) (13,14): group I
with A-TP≤1.5 g/dl (N = 16) and group II
with A-TP>1.5 g/dl (N = 14).
The parameters of the Child-Pugh (15)
classification were used for comparison of
the two groups. Ascitic fluid was considered
to be tense when the viscera could not be felt
during the physical examination of the abdo-
men, and moderate when the viscera were
directly palpated or felt by ballottement (16).
Ascitic fluid was obtained by means of
sterile paracentesis, and stored as aliquots at
-70oC for less than 6 months; 9 ml of blood in
1 ml of 3.8% sodium citrate was collected
from fasting patients from a peripheral vein
on the same day of the paracentesis proce-
dure. Plasma was centrifuged at 2,500 rpm
and stored in 2-ml aliquots at -70oC.
Plasma and ascitic fluid total protein was
determined by biuret reagent colorimetry.
The simple radial immunodiffusion tech-
nique with NOR-Partigen C3c and C4 plates
(Behring, Marburg, Germany) was used to
determine  C3 and C4 levels, using human
serum with known C3c and C4 concentra-
tions (Behring) as a standard. The same tech-
nique was used to determine plasma and
ascitic fluid fibronectin concentration using
human fibronectin antibodies (Sigma Chem-
ical Co., St. Louis, MO). Agar plates were
prepared using anti-fibronectin antibodies at
1/100 concentration and placing 20 µl of
blood or ascitic fluid in 4-mm diameter ori-
fices. Standard human plasma protein dilu-
tions (Behring) containing a known fibro-
nectin concentration (250 mg/l) were used to
obtain a reference curve for the glycoprotein
concentrations.
The Student t-test was used to compare
mean values between groups; the chi-square
test complemented by the Fisher exact test
was used to compare frequencies within each
group, and the Pearson correlation coeffi-
cient was used to correlate the studied vari-
ables (17). In all tests, the level of signifi-
cance was set at P<0.05.
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Results
No significant differences in age, race,
sex, etiology, Child-Pugh classification, or
the use of diuretics were observed between
the groups studied (Table 1). Spironolactone
was the diuretic used with a maximum daily
dose of 200 mg.
Based on the parameters used for the
Child-Pugh classification, only the ascitic
fluid tension differed between groups (Table
2).
The mean concentration of C3, C4, and
fibronectin (A-FN) in the ascitic fluid and
fibronectin in plasma (P-FN) was signifi-
cantly lower in the patients of the group at
higher risk for SBP (Table 3).
A statistically significant correlation was
observed between A-TP and A-FN (r = 0.73,
Figure 1) and the C3 fraction (r = 0.71) of the
ascitic fluid complement. A lower, but sig-
nificant correlation was observed between
A-TP and the C4 fraction (r = 0.52) of the
complement and with P-FN (r = 0.50).
Ascitic fluid fibronectin was also signif-
icantly correlated with the C3 (r = 0.76,
Figure 2) and C4 (r = 0.58) fractions of the
complement and with P-FN (r = 0.58).
Since A-FN and P-FN concentrations dif-
fered between groups and showed a signifi-
cant positive correlation, we determined the
P-FN and A-FN ratio and gradient, which
did not differ between groups.
Patients classified as having tense ascitic
fluid presented significantly lower fibronec-
tin levels than patients classified as having
moderately tense ascitic fluid.
Discussion
Spontaneous bacterial peritonitis is a se-
rious cirrhosis complication because of its
frequency and mortality rates (2,18) and be-
cause of its unclear clinical picture. For cir-
rhotic patients to develop SBP in their ascitic
fluid, a translocation of the intestinal bacte-
ria due to portal hypertension should occur
(13,18), and a reduction in the ascitic fluid
opsonic activity (2,4,19) should occur as
indicated by the low-protein concentration
in this fluid (2,3,13,20). Since fibronectin is
active in the opsonic process (5,21), its in-
volvement in the defense mechanisms pro-
tecting against infection has been investi-
gated. Several investigators have observed
an association between low fibronectin lev-
els in the ascitic fluid and the risk of SBP in
cirrhotic patients (7,10), although others have
not confirmed these findings (4,8). Although
Table 1 - Age, color, sex, etiology, Child-Pugh classification and use
of diuretics among cirrhotic patients grouped according to total
protein concentration in the ascitic fluid (A-TP).
N = Number of patients; aothers = viral or cryptogenic. There were
no significant differences between groups when the Student t-test
was used for age and the chi-square test was used for all other
parameters.
Group I Group II
A-TP≤1.5 g/dl A-TP>1.5 g/dl
(N = 16) (N = 14)
Age (mean ± SD) 51.12 ± 11.40 51.14 ± 8.31
Color (white/others) 11/5 9/5
Sex (masculine/feminine) 14/2 11/3
Etiology (alcohol/othersa) 12/4 11/3
Child-Pugh (A/B/C) 1/8/7 1/8/5
Use of diuretics (yes/no) 13/3 12/2
Table 2 - Clinical and biochemical parameters used for Child-Pugh
classification of cirrhotic patients grouped according to total protein
concentration in the ascitic fluid (A-TP).
There were no significant differences between groups according to
the aStudent t-test or bchi-square test, except for ascites. *P<0.05
compared to group I.
Group I Group II
A-TP≤1.5 g/dl A-TP>1.5 g/dl
(N = 16) (N = 14)
Total bilirubin (mg/dl)a 3.21 ± 4.37 2.06 ± 1.47
Prothrombin activity (%)a 48.05 ± 12.76 47.73 ± 11.25
Serum albumin (g/dl)a 3.16 ± 0.41 3.23 ± 0.50
Ascites (tense/moderate)b 13/3 4/10*
Encephalopathy (absent/present)b 12/4 11/3
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total protein and the opsonic activity in the
fluid (4,11).
The present study investigated the fibro-
nectin concentration in the ascitic fluid of
cirrhotic patients who were separated into
two groups according to high or low levels of
total protein concentration in the ascitic fluid.
Total protein in the ascitic fluid is the most
widely used biochemical parameter for iden-
tifying cirrhotic patients at risk for SBP. Its
methodological simplicity and high prog-
nostic value have been demonstrated by pro-
spective studies (3,13,14,20).
Significant differences in the C3 and C4
values and the degree of tension of the as-
citic fluid were observed between the groups
which were divided according to total pro-
tein values higher or lower than 1.5 g/dl
(13,14). The present findings confirmed that
these groups have different opsonic activi-
ties in the ascitic fluid and therefore differ-
ent risk levels for developing SBP. The higher
frequency of tense ascitic fluid in cirrhotic
patients with lower levels of A-TP indirectly
shows that the dilution factor determines not
only the low levels of total protein but also of
C3 and C4 in the ascitic fluid (2,18).
Fibronectin concentration was signifi-
cantly lower in patients biochemically char-
acterized as being at risk for SBP when
compared with patients with higher ascites
total protein levels, suggesting that this pa-
rameter may also be a criterion for the risk of
SBP. This possibility was further strength-
ened by the calculation of the correlation
between individual fibronectin values and
biochemical SBP risk factors. The positive
and highly significant correlation between
fibronectin and the C3 and C4 fractions of
the complement and A-TP further empha-
sizes the possible role of this glycoprotein in
local defense mechanisms of ascitic fluid,
corroborating the findings of Runyon (11)
and Mal et al. (4) who found a significant
correlation between A-FN and the opsonic
activity of the fluid.
The low fibronectin levels found in the
Table 3 - C3, C4, and fibronectin concentration in the ascitic fluid (A-
FN) and plasma (P-FN) of patients with liver cirrhosis.
Data are reported as means ± SD. *P<0.05 compared to group I
(Student t-test).
Group I Group II
A-TP≤1.5 g/dl A-TP>1.5 g/dl
(N = 16) (N = 14)
Ascites C3 (mg/dl) 12.59 ± 4.72 24.53 ± 15.58*
Ascites C4 (mg/dl) 4.26 ± 3.87 7.26 ± 4.14*
A-FN (mg/l) 50.47 ± 12.49 75.89 ± 24.70*
P-FN (mg/l) 193.75 ± 64.17 270.71 ± 65.12*
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A
-T
P
 (g
/d
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A-FN (mg/l)
r = 0.73
r = 0.76
Figure 1 - Correlation between fibronectin (A-FN) and total protein (A-TP)
in the ascitic fluid.
Figure 2 - Correlation between fibronectin (A-FN) and C3 concentrations
in the ascitic fluid.
the correlation between fibronectin levels in
the ascitic fluid and clinical and biochemical
risk factors for developing SBP has not been
widely investigated in these patients, it is
well known that fibronectin levels in the
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ascitic fluid may only reflect its low level in
plasma observed in the advanced stages of
cirrhosis of the liver (14,22). Thus, we evalu-
ated the relationship between the fibronectin
concentration in the ascitic fluid and in the
plasma of these patients by studying the
gradient and ratio of these variables. The
comparison of plasma and ascitic fibronec-
tin gradient and ratio, unlike the isolated
measurement of each one, did not show any
difference between groups, indicating that
changes in plasma and ascitic fluid levels of
fibronectin are related. These observations
corroborate the findings of Hafter et al. (23)
that plasma fibronectin is the main factor
determining the levels of this glycoprotein in
ascitic fluid.
The present data show that fibronectin
concentrations may be used as a risk indica-
tor for SBP in cirrhotic patients. Further
prospective studies on a larger number of
subjects, correlating fibronectin levels in the
ascitic fluid with SBP, are needed to validate
these findings.
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